Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach

被引:166
作者
Bezard, E [1 ]
Gross, CE [1 ]
机构
[1] Univ Bordeaux 2, Neurophysiol Lab, CNRS, UMR 5543,Basal Gang, F-33076 Bordeaux, France
关键词
D O I
10.1016/S0301-0082(98)00006-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This paper provides an overview of the compensatory mechanisms which come into action during experimental and human parkinsonism. The intrinsic properties of the dopaminergic neurones of the substantia nigra pars compacta (SNc) which degenerate during Parkinson's disease are described in detail. It is generally considered that the nigrostriatal pathway is principally responsible for the compensatory preservation of dopaminergic function. It is also becoming clear that the morphological characteristics of dopaminergic neurones and the dual character, synaptic and asynaptic, of striatal dopaminergic innervation engender two modes of transmission, wiring and volume, and that both these modes play a role in the preservation of dopaminergic Function. The plasticity of the dopamine neurones, extrinsic or intrinsic to the striatum, can thus be regarded as another compensatory mechanism. Recent anatomical and electrophysiological studies have shown that the SNc receives both glutamatergic and cholinergic inputs. The dynamic role this innervation plays in compensatory mechanisms in the course of the disease is explained acid discussed. Recent developments in the field of compensatory mechanisms speak for the urgence to develop a valid chronic model of Parkinsons disease, integrating all the clinical features, even resting tremor, and illustrating the gradual evolution of nigral degeneration observed in human Parkinson's disease. Only a dynamic approach to the physiopathological study of compensatory mechanisms in the basal ganglia will be capable of elucidating these complex questions. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:93 / 116
页数:24
相关论文
共 374 条
  • [71] TONIC ACTIVATION OF NMDA RECEPTORS CAUSES SPONTANEOUS BURST DISCHARGE OF RAT MIDBRAIN DOPAMINE NEURONS INVIVO
    CHERGUI, K
    CHARLETY, PJ
    AKAOKA, H
    SAUNIER, CF
    BRUNET, JL
    BUDA, M
    SVENSSON, TH
    CHOUVET, G
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1993, 5 (02) : 137 - 144
  • [72] SUBTHALAMIC NUCLEUS MODULATES BURST FIRING OF NIGRAL DOPAMINE NEURONS VIA NMDA RECEPTORS
    CHERGUI, K
    AKAOKA, H
    CHARLETY, PJ
    SAUNIER, CF
    BUDA, M
    CHOUVET, G
    [J]. NEUROREPORT, 1994, 5 (10) : 1185 - 1188
  • [73] PRESYNAPTIC REGULATION OF NEUROTRANSMITTER RELEASE IN THE BRAIN - FACTS AND HYPOTHESIS
    CHESSELET, MF
    [J]. NEUROSCIENCE, 1984, 12 (02) : 347 - 375
  • [74] CHIUEH CC, 1984, PSYCHOPHARMACOL BULL, V20, P548
  • [75] PRIMATE MODEL OF PARKINSONISM - SELECTIVE LESION OF NIGROSTRIATAL NEURONS BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE PRODUCES AN EXTRAPYRAMIDAL SYNDROME IN RHESUS-MONKEYS
    CHIUEH, CC
    BURNS, RS
    MARKEY, SP
    JACOBOWITZ, DM
    KOPIN, IJ
    [J]. LIFE SCIENCES, 1985, 36 (03) : 213 - 218
  • [76] DA uptake sites, D-1 and D-2 receptors, D-2 and preproenkephalin mRNAs and fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration
    Chritin, M
    Blanchard, V
    RaismanVozari, R
    Feuerstein, C
    Agid, Y
    JavoyAgid, F
    Savasta, M
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (12) : 2511 - 2520
  • [77] INTRASTRIATAL DOPAMINE-RICH IMPLANTS REVERSE THE INCREASE OF DOPAMINE D2 RECEPTOR MESSENGER-RNA LEVELS CAUSED BY LESION OF THE NIGROSTRIATAL PATHWAY - A QUANTITATIVE INSITU HYBRIDIZATION STUDY
    CHRITIN, M
    SAVASTA, M
    MENNICKEN, F
    BAL, A
    ABROUS, DN
    LEMOAL, M
    FEUERSTEIN, C
    HERMAN, JP
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1992, 4 (07) : 663 - 672
  • [78] DETECTING BEHAVIORALLY RELEVANT CHANGES IN EXTRACELLULAR DOPAMINE WITH MICRODIALYSIS
    CHURCH, WH
    JUSTICE, JB
    NEILL, DB
    [J]. BRAIN RESEARCH, 1987, 412 (02) : 397 - 399
  • [79] INCREASE IN STRIATAL DOPAMINE D2-RECEPTOR MESSENGER-RNA AFTER LESIONS OF HALOPERIDOL TREATMENT
    COIRINI, H
    SCHUMACHER, M
    ANGULO, JA
    MCEWEN, BS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 186 (2-3) : 369 - 371
  • [80] NIGROSTRIATAL LESIONS ENHANCE STRIATAL APOMORPHINE-H-3 AND H-3-SPIROPERIDOL BINDING
    CREESE, I
    SNYDER, SH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 56 (03) : 277 - 281